| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Serine/threonine-protein kinase PAK 1 |
|---|
| Ligand | BDBM205483 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Competitive Binding Assay (KINOMEscan) |
|---|
| Kd | >10000±n/a nM |
|---|
| Citation |  Murphy, EA; Cheresh, DA; Arnold, LD Therapeutic methods and compositions involving allosteric kinase inhibition US Patent US9260417 Publication Date 2/16/2016 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Serine/threonine-protein kinase PAK 1 |
|---|
| Name: | Serine/threonine-protein kinase PAK 1 |
|---|
| Synonyms: | 2.7.11.1 | Alpha-PAK | Cell division control protein 42 homolog | PAK 1/CDC42 | PAK-1 | PAK1 | PAK1_HUMAN | Serine/threonine-protein kinase PAK 1/PAK 2/PAK 3 | p21-activated kinase 1 | p65-PAK |
|---|
| Type: | n/a |
|---|
| Mol. Mass.: | 60640.15 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q13153 |
|---|
| Residue: | 545 |
|---|
| Sequence: | MSNNGLDIQDKPPAPPMRNTSTMIGAGSKDAGTLNHGSKPLPPNPEEKKKKDRFYRSILP
GDKTNKKKEKERPEISLPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKSEQKKN
PQAVLDVLEFYNSKKTSNSQKYMSFTDKSAEDYNSSNALNVKAVSETPAVPPVSEDEDDD
DDDATPPPVIAPRPEHTKSVYTRSVIEPLPVTPTRDVATSPISPTENNTTPPDALTRNTE
KQKKKPKMSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQ
MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC
MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK
RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG
TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA
TKNNH
|
|
|
|---|
| BDBM205483 |
|---|
| n/a |
|---|
| Name | BDBM205483 |
|---|
| Synonyms: | US9260417, 6 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C20H16F3N7OS |
|---|
| Mol. Mass. | 459.448 |
|---|
| SMILES | CSc1nc(N)cc(Oc2ccc(cc2)-c2nnc(Nc3cccc(c3)C(F)(F)F)[nH]2)n1 |
|---|
| Structure | 
|
|---|
Search and Browse
